Skip to main content
. 2016 Aug 26;14(1):228. doi: 10.1186/s12957-016-0985-3

Table 1.

Clinicopathological characteristics of the 19 patients in the training data set

Non-relapse Relapse p value
Case number 5 14
Age (mean ± SD) 68.4 ± 10.7 61 ± 9.6 0.111
Gender
 Male 3 14 0.012
 Female 2 0
Tumor location
 Upper/middle thoracic 1 7 0.244
 Lower thoracic 4 7
 Histological grade
 Well/moderate 4 13 0.421
 Poorly 1 1
Pathologic tumor depth
 T1-2 3 3 0.111
 T3-4 2 11
Lymph node metastasis
 N0 2 3 0.418
 N1-3 3 11
Distant metastasis
 M0 5 14
 M1 0 0
TNM stage (IUAC TNM Classification 7th edition)
 1–2 3 4 0.211
 3–4 2 10
Lymphatic vessel invasion
 Negative 2 3 0.418
 Positive 3 11
Venous invasion
 Negative 3 4 0.211
 Positive 2 10
Curability
 R0 5 14
 R1 0 0
 Preoperative chemotherapy 0 2
 Preoperative chemo radiation therapy (CRT) 0 1
 Postoperative chemotherapy 0 2
 Postoperative CRT 1 5
 Observation period (month, mean ± SD) 138.7 ± 45.1 14 ± 9.2 <0.001
 Duration between surgery and tumor relapse 10 ± 8.4
Type of tumor relapse
 Liver (H) 0 5
 Lymph node (Ly) 0 2
 Local (L) 0 1
 H + Ly 0 4
 Ly + L 0 2